⌘K

Home/Filings/4/0001493152-22-011361

4//SEC Filing

Bruce Gerald W 4

Accession 0001493152-22-011361

CIK 0001708331other

View on SEC.gov Company Profile

Filed

Apr 26, 8:00 PM ET

Accepted

Apr 27, 6:00 PM ET

Size

5.1 KB

Accession

0001493152-22-011361

Insider Transaction Report

Form 4

Period: 2022-04-25

Virpax Pharmaceuticals, Inc.VRPX

Director

Transactions

Award
Stock Option (right to buy)
2022-04-25+60,000→ 60,000 total
Exercise: $1.76From: 2022-04-25Exp: 2032-04-25→ Common Stock (60,000 underlying)

Documents

1 file

4
ownership.xmlPrimary

Issuer

Virpax Pharmaceuticals, Inc.

CIK 0001708331

Entity typeother

Related Parties

1

filerCIK 0001361013

Filing Metadata

Form type: 4
Filed: Apr 26, 8:00 PM ET
Accepted: Apr 27, 6:00 PM ET
Size: 5.1 KB

View on SEC.gov